Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

BACKGROUND: Osteoporosis is an abnormal reduction in bone mass and bone deterioration leading to increased fracture risk. Etidronate belongs to the bisphosphonate class of drugs which act to inhibit bone resorption by interfering with the activity of osteoclasts. OBJECTIVES: To assess the efficacy o...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cochrane Database Syst Rev
Hoofdauteurs: Wells, George A, Cranney, Ann, Peterson, Joan, Boucher, Michel, Shea, Beverley, Welch, Vivian, Coyle, Doug, Tugwell, Peter
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons, Ltd 2008
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6999803/
https://ncbi.nlm.nih.gov/pubmed/18254018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003376.pub3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items